1. Home
  2. ATXG vs SNPX Comparison

ATXG vs SNPX Comparison

Compare ATXG & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXG
  • SNPX
  • Stock Information
  • Founded
  • ATXG 2014
  • SNPX 2012
  • Country
  • ATXG China
  • SNPX United States
  • Employees
  • ATXG N/A
  • SNPX 5
  • Industry
  • ATXG Professional Services
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • ATXG Consumer Discretionary
  • SNPX Health Care
  • Exchange
  • ATXG Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • ATXG 3.9M
  • SNPX 3.7M
  • IPO Year
  • ATXG N/A
  • SNPX N/A
  • Fundamental
  • Price
  • ATXG $0.65
  • SNPX $2.69
  • Analyst Decision
  • ATXG
  • SNPX Strong Buy
  • Analyst Count
  • ATXG 0
  • SNPX 1
  • Target Price
  • ATXG N/A
  • SNPX $14.00
  • AVG Volume (30 Days)
  • ATXG 13.0K
  • SNPX 13.4K
  • Earning Date
  • ATXG 02-12-2025
  • SNPX 11-12-2024
  • Dividend Yield
  • ATXG N/A
  • SNPX N/A
  • EPS Growth
  • ATXG N/A
  • SNPX N/A
  • EPS
  • ATXG N/A
  • SNPX N/A
  • Revenue
  • ATXG $4,958,444.00
  • SNPX N/A
  • Revenue This Year
  • ATXG N/A
  • SNPX N/A
  • Revenue Next Year
  • ATXG N/A
  • SNPX N/A
  • P/E Ratio
  • ATXG N/A
  • SNPX N/A
  • Revenue Growth
  • ATXG N/A
  • SNPX N/A
  • 52 Week Low
  • ATXG $0.49
  • SNPX $2.32
  • 52 Week High
  • ATXG $1.77
  • SNPX $8.78
  • Technical
  • Relative Strength Index (RSI)
  • ATXG 48.03
  • SNPX 45.01
  • Support Level
  • ATXG $0.59
  • SNPX $2.52
  • Resistance Level
  • ATXG $0.66
  • SNPX $2.80
  • Average True Range (ATR)
  • ATXG 0.05
  • SNPX 0.21
  • MACD
  • ATXG 0.00
  • SNPX -0.01
  • Stochastic Oscillator
  • ATXG 50.38
  • SNPX 33.32

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: